P
81.93
0.98 (1.21%)
前收盘价格 | 80.95 |
收盘价格 | 80.56 |
成交量 | 234,621 |
平均成交量 (3个月) | 372,400 |
市值 | 4,058,631,936 |
市盈率 (P/E TTM) | 19.23 |
预期市盈率 (P/E Forward) | 17.24 |
价格/销量 (P/S) | 3.67 |
股市价格/股市净资产 (P/B) | 2.27 |
52周波幅 | |
利润日期 | 8 May 2025 |
营业毛利率 | 19.13% |
营业利益率 (TTM) | 31.68% |
稀释每股收益 (EPS TTM) | 4.26 |
季度收入增长率 (YOY) | 2.70% |
季度盈利增长率 (YOY) | 15.10% |
总债务/股东权益 (D/E MRQ) | 57.43% |
流动比率 (MRQ) | 3.68 |
营业现金流 (OCF TTM) | 256.57 M |
杠杆自由现金流 (LFCF TTM) | 191.75 M |
资产报酬率 (ROA TTM) | 6.19% |
股东权益报酬率 (ROE TTM) | 12.62% |
市场趋势
短期 | 中期 | ||
行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
股票 | Prestige Consumer Healthcare In | 看涨 | 看涨 |
AIStockmoo 评分
1.4
分析师共识 | 4.0 |
内部交易活动 | NA |
价格波动 | 2.0 |
技术平均移动指标 | 1.5 |
技术振荡指标 | -2.0 |
平均 | 1.38 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |
|
部门 | Healthcare |
行业 | Drug Manufacturers - Specialty & Generic |
投资方式 | Small Core |
内部持股比例 | 1.30% |
机构持股比例 | 109.12% |
52周波幅 | ||
目标价格波幅 | ||
高 | 97.00 (RBC Capital, 18.39%) | 保留 |
中 | 95.00 (15.95%) | |
低 | 93.00 (Oppenheimer, 13.51%) | 购买 |
平均值 | 95.00 (15.95%) | |
总计 | 1 购买, 1 保留 | |
平均价格@调整类型 | 84.95 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
RBC Capital | 21 Mar 2025 | 97.00 (18.39%) | 保留 | 84.21 |
Oppenheimer | 13 Feb 2025 | 93.00 (13.51%) | 购买 | 85.68 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合